- Previous Close
2.6200 - Open
2.6000 - Bid 2.6200 x --
- Ask 2.7000 x --
- Day's Range
2.5800 - 2.7300 - 52 Week Range
0.4500 - 4.9700 - Volume
5,154 - Avg. Volume
102,301 - Market Cap (intraday)
126.424M - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
16.75 - EPS (TTM)
0.1600 - Earnings Date --
- Forward Dividend & Yield 0.04 (1.49%)
- Ex-Dividend Date Nov 5, 2024
- 1y Target Est
5.45
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates through Brought in Lines and Company Owned Products segments. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers. In addition, the company engages in research, development, and sale of genomics. Further, it offers precision nutrition research products under the EZZ brand. EZZ Life Science Holdings Limited offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.
ezzlife.com.auRecent News: EZZ.AX
View MorePerformance Overview: EZZ.AX
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EZZ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EZZ.AX
View MoreValuation Measures
Market Cap
126.42M
Enterprise Value
107.53M
Trailing P/E
16.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.74
Price/Book (mrq)
5.93
Enterprise Value/Revenue
1.62
Enterprise Value/EBITDA
10.36
Financial Highlights
Profitability and Income Statement
Profit Margin
10.48%
Return on Assets (ttm)
28.12%
Return on Equity (ttm)
38.79%
Revenue (ttm)
66.44M
Net Income Avi to Common (ttm)
6.96M
Diluted EPS (ttm)
0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
19.58M
Total Debt/Equity (mrq)
0.58%
Levered Free Cash Flow (ttm)
4.65M